St. Jude Medical Reports Second Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St recovers as yields ease; Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- FOMC minutes from July 28-29th meeting
Deutsche Bank Downgrades St. Jude Medical (STJ) to Hold
July 23, 2015 7:17 AM EDTDeutsche Bank downgraded St. Jude Medical (NYSE: STJ) from Buy to Hold with a price target of $77.00 (from $76.00). The downgrade follows recent outperformance.
Analyst Kisten Stewart said, "We upgraded STJ shares to Buy in Feb 2011 after its investor day as we were impressed... More
St. Jude Medical (STJ) PT Raised to $80 at Evercore ISI on Thoratec Accretion
July 22, 2015 1:57 PM EDTEvercore ISI analyst Vijay Kumar raised estimates and his price target on St. Jude Medical (NYSE: STJ) to $80.00 (from $77.50) following the acquisition of Thoratec (NASDAQ: THOR) but maintained a Hold rating.
Kumar commented, "STJ's quarterly results took a backseat with investors mainly focused on the announcement of acquisition of Thoratec, a leading LVAD (left ventricular assist device) player for Class IV heart failure patients. Strategically the acquisition makes sense for STJ, given its... More
St. Jude Medical (STJ) Tops Q2 EPS by 2c
July 22, 2015 7:06 AM EDTSt. Jude Medical (NYSE: STJ) reported Q2 EPS of $1.02, $0.02 better than the analyst estimate of $1.00. Revenue for the quarter came in at $1.41 billion versus the consensus estimate of $1.39 billion.
St. Jude Medical sees Q3 2015 EPS of $0.96-$0.98, versus the consensus of... More
